Posted by & filed under Control, Decision Making, Ethics & Social Responsibility, International Business, Leadership, Management, Strategy.

Description: Americans are moving on from COVID-19. Most public places, transit, and municipalities have gotten rid of mask mandates. Vaccine booster rates have plateaued, even with the introduction of a new “bivalent” shot targeting multiple variants, including Omicron.

Source: Yahoo.Finance.com – video report

Date: Oct 18, 2022

Link: https://ca.finance.yahoo.com/news/pfizer-ceo-2023-pivotal-year-as-covid-19-drug-sales-wane-195020896.html

Questions for discussion:

  • How is the company attempting to deal with expected decline in Covid vaccine sales?
  • Why would collaborations with other pharmas work well for Pfizer?
  • Would you be an investor is Pfizer today?